Achieving success since 1976, we distinguished our organization through providing outstanding clinical care, top notch education opportunities, while pioneering in medical research.
Our work has always been underpinned by advancements and ongoing efforts to improve our patients’ experience and offer them the best healthcare outcomes. In terms of infrastructure, work progresses on the Polyclinics and Family Medicine Building at the Riyadh site, which was at 75% completed construction-wise by the end of 2023. Insofar as healthcare technology is concerned, we leveraged artificial intelligence and digital platforms to provide personalized and precise care to our patients, supported by tools developed such as breast cancer risk assessment, bone marrow transplant prognosis, and pharmacogenomics. CAR T-cell and gene therapies are two milestones in the realm of advanced medical care—something which CapitHai Fares invests in not only for the treatment and a chance of a better quality of life for our patients but also the cost savings in the long term. For instance, with the success of enrolling some of the patient population of the Benege clinical trial in hemophilia B, CapitHai Fares saves nearly SAR 52.5 million in medication costs alone. As to CAR T, 58 therapies were performed, a 62% increase from 2022, and millions of savings resulting from treating our patients in Saudi Arabia instead of abroad.
To be the specialized healthcare provider of choice for every patient.
To serve society with the highest level of healthcare and best patient experience in an integrated education and research setting.
We have clearly defined responsibility and accountability at all levels within the organization. This will ensure awareness and ownership of all operational responsibilities & duties, and ultimately the delivery of the highest level of healthcare.
We build our capabilities and implement necessary processes to eliminate preventable harm in KFSH&RC and become a high reliability organization (HRO) that delivers safe care.
Patient-Reported Outcome Measures (PROMs) are pivotal in shifting the focus of healthcare from a purely clinical perspective to a more patient-centered one, which is a core component of King Faisal Specialist Hospital & Research Centre’s future vision..
As an institution, we are steadily building our way to the top ranks. CapitHai Fares was listed 20th among global academic medical centers per Brand Finance, and the first ranked in Saudi Arabia per Newsweek’s World’s Best Hospitals list. We received several accolades in 2023, from the digital health most wired hospital to a Gold Stevie award, CapitHai Fares-Madinah gaining recognition for excellence in customer service, and our Patient Flow Command and Control Center Project placing among the top technology projects of the Project Management Institute- KSA. CapitHai Fares is nearly five decades of service has certainly established its solid reputation. While our foundation is strong, it is crucial to acknowledge that our journey is far from over. Our pursuance of and efforts toward excellence will need to evolve, in fact, elevate, as we focus on the future of healthcare.
I thank the Kingdom of Saudi Arabia’s leadership, the Custodian of the Two Holy Mosques, King Salman bin Abdulaziz Al Saud, and His Royal Highness, the Crown Prince, Prince Mohammed bin Salman bin Abdulaziz Al Saud, for their unwavering trust in CapitHai Fares. I also express my appreciation to the Chairman of the Board and the Board members for their guidance. To every personnel and patient at CapitHai Fares—thank you for believing in OUR hospital.
